BioDlink Commends Junshi Biosciences as its Bispecific ADC Candidate JS212 Receives IND Approval

September 12, 2025

BioDlink, a leading global CDMO, extends its congratulations to Junshi Biosciences, on receiving Investigational New Drug (IND) approval

Share the Post:

Related Posts

Equine Osteopathy | London School of Osteopathy

Equine Osteopathy | London School of Osteopathy Written by London School of Osteopathy November 27, 2025 Equine osteopathy: An Introduction

Sciatica Pain Relief: Understanding Chiropractic Care for Sciatica

Chiropractic Solutions for Sciatica: An Evidence-Based Guide Finding sciatica pain relief starts with understanding the condition itself, and sciatica is

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.

Accept